1-[2-[4-[(2,4-difluorophenyl)methyl]piperazin-1-yl]-3-(ethylamino)pyrido[3,4-b]pyrazin-7-yl]-2-methylpropan-2-ol
C24H30F2N6O — CID 177190927
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2-[4-[(2,4-difluorophenyl)methyl]piperazin-1-yl]-3-(ethylamino)pyrido[3,4-b]pyrazin-7-yl]-2-methylpropan-2-ol
1-[2-[4-[(2,4-difluorophenyl)methyl]piperazin-1-yl]-3-(ethylamino)pyrido[3,4-b]pyrazin-7-yl]-2-methylpropan-2-ol (PubChem CID 177190927) has the molecular formula C24H30F2N6O and a molecular weight of 456.54 g/mol. Its IUPAC name is 1-[2-[4-[(2,4-difluorophenyl)methyl]piperazin-1-yl]-3-(ethylamino)pyrido[3,4-b]pyrazin-7-yl]-2-methylpropan-2-ol.
Molecular Properties
| Compound Name | 1-[2-[4-[(2,4-difluorophenyl)methyl]piperazin-1-yl]-3-(ethylamino)pyrido[3,4-b]pyrazin-7-yl]-2-methylpropan-2-ol |
|---|---|
| PubChem CID | 177190927 |
| Molecular Formula | C24H30F2N6O |
| Molecular Weight | 456.54 g/mol |
| Exact Mass | 456.24 |
| IUPAC Name | 1-[2-[4-[(2,4-difluorophenyl)methyl]piperazin-1-yl]-3-(ethylamino)pyrido[3,4-b]pyrazin-7-yl]-2-methylpropan-2-ol |
| SMILES | CCNc1nc2cnc(CC(C)(C)O)cc2nc1N1CCN(Cc2ccc(F)cc2F)CC1 |
| InChI | InChI=1S/C24H30F2N6O/c1-4-27-22-23(30-20-12-18(13-24(2,3)33)28-14-21(20)29-22)32-9-7-31(8-10-32)15-16-5-6-17(25)11-19(16)26/h5-6,11-12,14,33H,4,7-10,13,15H2,1-3H3,(H,27,29) |
| InChIKey | UKOIVJAHXVIWQA-UHFFFAOYSA-N |
| XLogP | 3.37 |
| TPSA | 77.41 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 456.54 |
| LogP ≤ 5 | 3.37 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177190927 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.